BioXcel Therapeutics signs asset sale agreement with Teva
BioXcel Therapeutics entered into an asset sale agreement with Teva Pharmaceuticals.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.